[TAp73α is Upregulated in the Most Common Human Cancers].

Area of Science:

• Molecular Biology
• Cancer Research
• Genetics

Background:

• The p73 protein, a member of the p53 tumor suppressor gene family, plays a crucial role in regulating apoptosis.
• The TP73 gene produces two main protein isoform classes: TAp73 and DNp73, which have distinct functions.
• Unlike TP53, the TP73 gene is not typically mutated in cancer, suggesting altered expression patterns are key.

Purpose of the Study:

• To investigate the expression levels of p73 isoforms (TAp73 and DNp73) across eight major human cancer types.
• To analyze publicly available cancer genomic data to understand p73 isoform dysregulation in tumors.

Main Methods:

• Utilized data from the Genomic Data Commons (GDC) data portal and the TSVdb database.
• Analyzed gene expression data for p73 isoforms in various cancer types.

Main Results:

• TAp73α was found to be overexpressed in breast invasive carcinoma, stomach adenocarcinoma, lung squamous cell carcinoma, colon adenocarcinoma, and esophageal carcinoma.
• DNp73 isoforms (including DNp73α, β, and γ) showed downregulation in breast invasive carcinoma, prostate adenocarcinoma, lung adenocarcinoma, and lung squamous cell carcinoma.
• A general trend of higher TAp73α expression compared to DNp73 isoforms was observed across several cancer types.

Conclusions:

• The study highlights differential expression patterns of p73 isoforms in major cancers.
• TAp73α overexpression and DNp73 downregulation are significant findings in the studied tumor types.
• These findings suggest a potential role for p73 isoform dysregulation in cancer development and progression.